127 related articles for article (PubMed ID: 6174137)
21. Prognostic factors in metastatic non-seminomatous germ cell tumours: the Medical Research Council studies.
Mead GM; Stenning SP
Eur Urol; 1993; 23(1):196-200; discussion 201. PubMed ID: 7682951
[TBL] [Abstract][Full Text] [Related]
22. [Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)].
Boewer C; Nawka S; Fleck H; Uibel M; Immer U; Schmidt HE; Herzmann H; Pilgrim G; Ziegenbein R
Z Urol Nephrol; 1985 Feb; 78(2):77-86. PubMed ID: 2581393
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors in metastatic nonseminomatous germ cell tumours.
Hanson PR; Belitsky P; Millard OH; Lannon SG
Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
[TBL] [Abstract][Full Text] [Related]
24. The value of AFP and HCG half lives in predicting the efficacy of combination chemotherapy in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):129-34. PubMed ID: 6170953
[TBL] [Abstract][Full Text] [Related]
25. Does extragonadal presentation impart a worse prognosis to abdominal germ-cell tumours?
McAleer JJ; Nicholls J; Horwich A
Eur J Cancer; 1992; 28A(4-5):825-8. PubMed ID: 1381929
[TBL] [Abstract][Full Text] [Related]
26. [Clinical outcome of adult testicular tumor. I. Study on patients of nonseminoma with negative human chorionic gonadotropin].
Kawai T; Sakuramoto T; Kihara K
Hinyokika Kiyo; 1984 May; 30(5):627-37. PubMed ID: 6089532
[TBL] [Abstract][Full Text] [Related]
27. An analysis of surveillance for stage I combined teratoma--seminoma of the testis.
Thomas R; Dearnaley D; Nicholls J; Norman A; Sampson S; Horwich A
Br J Cancer; 1996 Jul; 74(1):59-62. PubMed ID: 8679458
[TBL] [Abstract][Full Text] [Related]
28. The role of tumour markers and lymphography in determining clinical stage of non-seminomatous testis tumours.
Zvara V; Hornák M; Breza J; Krídl J
Czech Med; 1986; 9(1):9-14. PubMed ID: 2423305
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study. Report from the Medical Research Council Working Party on Testicular Tumours.
Lancet; 1985 Jan; 1(8419):8-11. PubMed ID: 2578205
[TBL] [Abstract][Full Text] [Related]
30. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
Skinner DG; Scardino PT
Trans Am Assoc Genitourin Surg; 1979; 71():31-5. PubMed ID: 94715
[No Abstract] [Full Text] [Related]
31. [Clinical observation of twelve cases of testicular cancer].
Takemae K; Tajiri S; Suzuki T; Hata S
Hinyokika Kiyo; 1987 Aug; 33(8):1199-206. PubMed ID: 2447765
[TBL] [Abstract][Full Text] [Related]
32. Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients.
Logothetis CJ; Swanson DA; Dexeus F; Chong C; Ogden S; Ayala AG; von Eschenbach AC; Johnson DE; Samuels ML
J Clin Oncol; 1987 Jun; 5(6):906-11. PubMed ID: 2438389
[TBL] [Abstract][Full Text] [Related]
33. Serum alpha-foetoprotein as a marker for endodermal sinus tumour (yolk sac tumour) or a vitelline component of "teratocarcinoma".
Norgaard-Pedersen B; Albrechtsen R; Teilum G
Acta Pathol Microbiol Scand A; 1975 Nov; 83(6):573-89. PubMed ID: 52995
[TBL] [Abstract][Full Text] [Related]
34. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
Gerl A; Clemm C; Lamerz R; Mann K; Wilmanns W
Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of marker half-life during chemotherapy in non-seminomatous germ cell testicular tumors.
Inanç SE; Meral R; Darendeliler E; Yasasever V; Onat H
Acta Oncol; 1999; 38(4):505-9. PubMed ID: 10418719
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
37. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
[TBL] [Abstract][Full Text] [Related]
38. Prostatic relapse of an undifferentiated teratoma 24 years after orchidectomy.
Janowitz T; Welsh S; Warren AY; Robson J; Thomas B; Shaw A; Ainsworth NL; Neal DE; Mazhar D
BMC Res Notes; 2015 Oct; 8():524. PubMed ID: 26428307
[TBL] [Abstract][Full Text] [Related]
39. Prognosis in patients with metastatic non-seminomatous testicular cancer.
Aass N; Fosså SD; Ous S; Stenwig AE; Lien HH; Paus E; Kaalhus O
Radiother Oncol; 1990 Apr; 17(4):285-92. PubMed ID: 1693003
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis and staging of germ-cell tumours of the testis].
Mottet N; Berger N; Droz JP
Rev Prat; 2007 Feb; 57(4):365-78. PubMed ID: 17455738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
